Marsh & McLennan Companies, Inc. (MRSH)
Official siteFINANCIAL SERVICES • INSURANCE BROKERS • NYSE
Market Cap: $98.80B
Last updated: Nov 17, 2026 at 11:06 AM ET
Marsh & McLennan Companies, Inc. (MRSH) Financials: Revenue, Profit and Cash Flow
Marsh & McLennan Companies reported revenue of $26.10B for the fiscal year ended Dec 31, 2025, up 9.4% from the year before. That year, net income was $4.23B with a net margin of 16.2%, operating cash flow was $5.29B and free cash flow was $5.00B. The quarter ended Sep 30, 2026 had revenue of $6.63B and net income of $812.00M.
Revenue and Margins
The operating margin was 23.8% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $13.03B, a compound annual rate of 8.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $26.10B | +9.4% | 43.7% | 23.8% | 16.2% |
| Dec 2024 | $23.85B | +7.2% | 43.9% | 24.4% | 17.3% |
| Dec 2023 | $22.24B | +9.6% | 43.3% | 23.7% | 17.1% |
| Dec 2022 | $20.29B | +4.4% | 42.6% | 21.1% | 15.2% |
| Dec 2021 | $19.44B | +14.7% | 43.2% | 22.2% | 16.3% |
| Dec 2020 | $16.95B | +4.9% | 41.9% | 18.1% | 12.1% |
| Dec 2019 | $16.16B | +10.2% | 42.8% | 16.6% | 11.0% |
| Dec 2018 | $14.66B | +6.3% | 43.3% | 18.8% | 11.4% |
| Dec 2017 | $13.80B | +5.9% | 43.0% | 19.2% | 11.0% |
| Dec 2016 | $13.03B | N/A | 42.4% | 18.7% | 13.8% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 2.7% from the year before. In the quarter ended Sep 2026, net income rose 7.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $26.10B | $23.85B | $22.24B | $20.29B | $19.44B | $16.95B | $16.16B | $14.66B | $13.80B | $13.03B |
| Cost of revenue | $15.58B | $14.00B | $13.10B | $12.07B | $11.43B | $10.13B | $9.73B | $8.61B | $8.09B | $7.69B |
| Gross profit | $11.40B | $10.46B | $9.64B | $8.65B | $8.39B | $7.09B | $6.92B | $6.34B | $5.94B | $5.52B |
| Operating income | $6.22B | $5.82B | $5.28B | $4.28B | $4.31B | $3.07B | $2.68B | $2.76B | $2.65B | $2.43B |
| Net income | $4.23B | $4.12B | $3.80B | $3.09B | $3.17B | $2.05B | $1.77B | $1.67B | $1.51B | $1.79B |
| EBITDA | $6.25B | $5.96B | $5.50B | $4.57B | $4.68B | $3.53B | $2.83B | $2.96B | $2.91B | $2.92B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.63B | $7.16B | $7.37B | $6.38B | $6.14B | $6.74B | $6.84B | $5.87B | $5.56B | $6.08B | $6.35B | $5.44B |
| Gross profit | N/A | N/A | $3.47B | $2.66B | $2.46B | $3.08B | $3.21B | $2.44B | $2.25B | $2.77B | $3.00B | $2.29B |
| Operating income | N/A | N/A | $1.75B | $1.22B | $1.17B | $1.83B | $2.00B | $1.14B | $1.11B | $1.64B | $1.93B | $1.10B |
| Net income | $812.00M | $1.29B | $1.19B | $834.00M | $757.00M | $1.23B | $1.41B | $801.00M | $752.00M | $1.14B | $1.42B | $765.00M |
Balance Sheet
As of Dec 2025, total debt of $19.59B exceeded cash and equivalents by $16.90B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $58.71B | $56.48B | $48.03B | $44.11B | $34.39B | $33.05B | $31.36B | $21.58B | $20.43B | $18.19B |
| Current assets | $23.20B | $22.12B | $21.75B | $18.96B | $8.26B | $8.12B | $7.07B | $5.93B | $5.56B | $4.88B |
| Cash and equivalents | $2.69B | $2.40B | $3.36B | $12.10B | $1.75B | $2.09B | $1.16B | $1.07B | $1.21B | $1.03B |
| Total liabilities | $43.40B | $42.95B | $35.66B | $33.37B | $23.17B | $23.79B | $23.41B | $13.99B | $12.99B | $11.92B |
| Short-term debt | $1.27B | $519.00M | $1.62B | $268.00M | $17.00M | $517.00M | $1.22B | $755.00M | $262.00M | $312.00M |
| Long-term debt | $18.32B | $19.43B | $11.84B | $11.23B | $10.93B | $10.80B | $10.74B | $5.51B | $5.22B | $4.50B |
| Shareholder equity | $15.10B | $13.34B | $12.19B | $10.52B | $11.01B | $9.10B | $7.79B | $7.51B | $7.36B | $6.19B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $59.81B | $59.68B | $58.55B | $58.71B | $58.78B | $58.55B | $57.02B | $56.48B | $49.86B | $48.59B | $47.57B | $48.03B |
| Total liabilities | $44.90B | $44.25B | $43.75B | $43.40B | $43.42B | $42.58B | $42.75B | $42.95B | $35.98B | $35.03B | $34.95B | $35.66B |
| Cash and equivalents | $1.84B | $1.70B | $1.61B | $2.69B | $2.51B | $1.68B | $1.60B | $2.40B | $1.80B | $1.65B | $12.91B | $3.36B |
| Shareholder equity | $14.68B | $15.18B | $14.57B | $15.10B | $15.15B | $15.77B | $14.06B | $13.34B | $13.69B | $13.37B | $12.42B | $12.19B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 94.5% of operating cash flow. Dividends and share repurchases together came to 75.4% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.29B | $4.30B | $4.26B | $3.46B | $3.52B | $3.38B | $2.36B | $2.43B | $1.89B | $2.01B |
| Capital expenditures | $291.00M | $316.00M | $416.00M | $470.00M | $406.00M | $348.00M | $421.00M | $314.00M | $302.00M | $253.00M |
| Free cash flow | $5.00B | $3.99B | $3.84B | $3.00B | $3.11B | $3.03B | $1.94B | $2.11B | $1.59B | $1.75B |
| Dividends paid | $1.76B | $1.55B | $1.33B | $1.17B | $1.06B | $977.00M | $906.00M | $807.00M | $740.00M | $682.00M |
| Share repurchases | $2.01B | $900.00M | $1.15B | $1.95B | $1.16B | $0 | $485.00M | $675.00M | $900.00M | $800.00M |
| Investing cash flow | -$845.00M | -$8.82B | -$1.42B | -$850.00M | -$1.16B | -$793.00M | -$4.39B | -$1.09B | -$956.00M | -$1.06B |
| Financing cash flow | -$4.63B | $4.46B | -$1.12B | -$1.05B | -$1.30B | -$925.00M | $4.33B | -$1.31B | -$1.01B | -$1.07B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.48B | $1.52B | -$688.00M | $2.16B | $2.08B | $1.67B | -$622.00M | $1.96B | $1.91B | $1.22B | -$781.00M | $1.78B |
| Capital expenditures | $81.00M | $72.00M | $62.00M | $105.00M | $72.00M | $59.00M | $55.00M | $76.00M | $73.00M | $80.00M | $87.00M | $120.00M |
| Free cash flow | $1.40B | $1.45B | -$750.00M | $2.06B | $2.01B | $1.61B | -$677.00M | $1.88B | $1.84B | $1.14B | -$868.00M | $1.66B |
Frequently Asked Questions About MRSH
What is Marsh & McLennan Companies' annual revenue?
Marsh & McLennan Companies reported revenue of $26.10B for the fiscal year ended Dec 31, 2025.
How fast is Marsh & McLennan Companies' revenue growing?
Revenue was up 9.4% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 8.8%.
Is Marsh & McLennan Companies profitable?
Yes. Marsh & McLennan Companies reported net income of $4.23B for the fiscal year ended Dec 31, 2025, with a net margin of 16.2%.
How much free cash flow does MRSH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $5.29B minus capital expenditures of $291.00M produced free cash flow of $5.00B.
How much debt does Marsh & McLennan Companies have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $18.32B, short-term debt of $1.27B and cash and equivalents of $2.69B.
MRSH pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts